Ralph Ermoian - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Ralph Ermoian

This paper is made freely available by the publisher.

2018 H. Joachim Deeg, Emily A. Stevens, Rachel B. Salit, Ralph P. Ermoian

ORCID

, Min Fang, Boglarka Gyurkocza, Mohamed L. Sorror, Giancarlo Fatobene

ORCID

, Joachim Baumgart, Lauri M. Burroughs, Colleen Delaney, Kris Doney, Daniel N. Egan, Mary E. D. Flowers, Filippo Milano and 6 other authors

Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2017 Avani D. Rao, Arif S. Rashid, Qinyu Chen, Rosangela C. Villar, Daria Kobyzeva, Kristina Nilsson, Karin Dieckmann, Alexey Nechesnyuk, Ralph Ermoian

ORCID

, Sara Alcorn, Shannon M. MacDonald, Matthew M. Ladra, Eric C. Ford, Brian A. Winey, Maria Luisa S. Figueiredo and 2 other authors

Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review

Upload

This paper was not found in any repository, but could be made available legally by the author.

Avani Dholakia Rao, Qinyu Chen, Ralph P. Ermoian

ORCID

, Sara R. Alcorn, Maria Luisa S. Figueiredo, Michael J. Chen, Karin Dieckmann, Shannon M. MacDonald, Matthew M. Ladra, Daria Kobyzeva, Alexey V. Nechesnyuk, Kristina Nilsson, Eric C. Ford, Brian A. Winey, Rosangela C. Villar and 1 other authors

Practice patterns of palliative radiation therapy in pediatric oncology patients in an international pediatric research consortium

Upload

This paper was not found in any repository, but could be made available legally by the author.

Ralph P. Ermoian

ORCID

, John Breneman, David O. Walterhouse, Yueh-Yun Chi, Jane Meza, James Anderson, Douglas S. Hawkins, Andrea A. Hayes-Jordan, David M. Parham, Torunn I. Yock, Sarah S. Donaldson, Suzanne L. Wolden

45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Upload

Missing publications? Search for publications with a matching author name.